NO973421D0 - Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA - Google Patents

Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA

Info

Publication number
NO973421D0
NO973421D0 NO973421A NO973421A NO973421D0 NO 973421 D0 NO973421 D0 NO 973421D0 NO 973421 A NO973421 A NO 973421A NO 973421 A NO973421 A NO 973421A NO 973421 D0 NO973421 D0 NO 973421D0
Authority
NO
Norway
Prior art keywords
dna
recombinant dna
heavy chain
recombinant
myosin heavy
Prior art date
Application number
NO973421A
Other languages
English (en)
Other versions
NO973421L (no
Inventor
Kazuhide Hasegawa
Emi Arakawa
Shoji Oda
Yuzuru Matsuda
Katsuhito Talahashi
Haruo Ishiyama
Original Assignee
Vessel Research Lab Co Ltd
Osaka Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vessel Research Lab Co Ltd, Osaka Prefecture filed Critical Vessel Research Lab Co Ltd
Publication of NO973421D0 publication Critical patent/NO973421D0/no
Publication of NO973421L publication Critical patent/NO973421L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO973421A 1995-01-25 1997-07-24 Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA NO973421L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1008595 1995-01-25
PCT/JP1996/000134 WO1996023069A1 (en) 1995-01-25 1996-01-25 Recombinant dna prepared by integrating dna that codes for myosin heavy-chain sm1 isoform protein into vector dna, and microorganism and arteriosclerosis remedy both containing the recombinant dna

Publications (2)

Publication Number Publication Date
NO973421D0 true NO973421D0 (no) 1997-07-24
NO973421L NO973421L (no) 1997-09-22

Family

ID=11740510

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973421A NO973421L (no) 1995-01-25 1997-07-24 Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA

Country Status (13)

Country Link
US (1) US6593304B1 (no)
EP (1) EP0806477B1 (no)
JP (1) JP3092944B2 (no)
KR (1) KR19980701695A (no)
AT (1) ATE236977T1 (no)
AU (1) AU711757B2 (no)
CA (1) CA2211468A1 (no)
DE (1) DE69627307T2 (no)
FI (1) FI973104L (no)
HU (1) HUP9801762A1 (no)
NO (1) NO973421L (no)
NZ (1) NZ300270A (no)
WO (1) WO1996023069A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11285333A (ja) * 1998-02-05 1999-10-19 Vessel Research Laboratory:Kk 変異型平滑筋ミオシン重鎖遺伝子を有する非ヒト動物の胚幹細胞および非ヒト動物
CN1321672A (zh) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 一种新的多肽——人肌球蛋白重链12－14和编码这种多肽的多核苷酸
US6974688B2 (en) 2001-08-10 2005-12-13 Cytokinetics, Inc. Human smooth muscle myosin heavy chain
US10590452B2 (en) 2017-12-20 2020-03-17 University Of Seoul Industry Cooperation Foundation DNA-Mn hybrid particles and method of manufacturing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0646841A (ja) * 1992-07-24 1994-02-22 Kyowa Hakko Kogyo Co Ltd トランスフェリン非要求性細胞

Also Published As

Publication number Publication date
DE69627307T2 (de) 2004-03-04
JP3092944B2 (ja) 2000-09-25
FI973104A7 (fi) 1997-09-24
WO1996023069A1 (en) 1996-08-01
EP0806477B1 (en) 2003-04-09
ATE236977T1 (de) 2003-04-15
AU4496196A (en) 1996-08-14
DE69627307D1 (de) 2003-05-15
HUP9801762A1 (hu) 1998-11-30
NZ300270A (en) 1998-09-24
CA2211468A1 (en) 1996-08-01
AU711757B2 (en) 1999-10-21
EP0806477A4 (en) 2000-01-05
US6593304B1 (en) 2003-07-15
EP0806477A1 (en) 1997-11-12
FI973104L (fi) 1997-09-24
KR19980701695A (ko) 1998-06-25
NO973421L (no) 1997-09-22
FI973104A0 (fi) 1997-07-24

Similar Documents

Publication Publication Date Title
NO981353D0 (no) Regulerte gener og anvendelser derav
DK1011673T3 (da) Hidtil ukendt metode til behandling af nidom
EP0885958A4 (en) METHOD FOR TREATING BIOPOLYMERS, MICROORGANISMS OR OTHER MATERIALS USING MORE THAN ONE TYPE OF MAGNETIC PARTICLES.
NO910982D0 (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
EP0303961A3 (en) Novel antidepressants
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DE69434209D1 (de) REGULATION DER GENEXPRESSION VON bcl-2
NO885275L (no) Vaskulaere antikoagulantproteiner, dna'er som koder for dem, fremstilling og anvendelse derav.
SE8803071D0 (sv) Bakteriebehandling for att bevara hokvalitet genom att tillegga genius bacillus mikroorganismer
FI961666A7 (fi) Restenosiksen geeniterapia, jossa käytetään adenovirusvektoria
DE69431825D1 (de) Delta-9 Desaturase und dafür kodierendes Gen
HU9700598D0 (en) Process for profilacting and treating pancreatitis
NO924576D0 (no) Kloning og ekspresjon av gener som koder for arabinan-nedbrytende enzymer av sopp-opprinnelse
NO973421D0 (no) Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA
DE69839582D1 (de) Neues polypeptid, dafür kodierende dna und deren verwendungen
NO944339D0 (no) Melatoninderivater for anvendelse ved behandling av sövnforstyrrelser
NO944340L (no) Melatoninderivater for anvendelse ved behandling av desynkroniseringstilstander
DE69332375D1 (de) Hundecoronavirus s gen und verwendung davon
NO20010345L (no) Fremgangsmåte og anordning til behandling av gasser, samt anvendelse derav
PT1133297E (pt) Nova aplicacao terapeutica da 1,6-dimetil-8beta-hidroximetil-10alfa-metoxiergolina
UA8280A (uk) Спосіб лікування псоріазу
DK0663955T3 (da) Nucleinsyre, som koder for en alfa-acetolactat-decarboxylase, og anvendelser deraf
UA32288A (uk) Спосіб лікування дегенеративних і запальних процесів
MX9707549A (es) Vectores virales y su uso para tratar trastornos hiperproliferativos, en particular restenosis.
ITPD960038V0 (it) Associazione di porfirina cationica e sorgente luminosa coerente o noncoerente per il trattamento di infezioni microbiche dell'endodonto e del periimpianto